Related Experiment Video
Updated: Feb 7, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Risk of stroke early after implantation of a left ventricular assist device
Takaaki Samura1, Daisuke Yoshioka1, Koichi Toda1
1Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Insights
Low cardiac output and high lactate dehydrogenase levels are key risk factors for stroke after left ventricular assist device implantation. Maintaining sufficient device flow may prevent acute stroke events.
Area of Science:
- Cardiology
- Neurology
- Medical Devices
Background:
- Stroke is a significant complication following left ventricular assist device (LVAD) implantation.
- The risk of stroke is elevated in the acute phase and chronic periods post-implantation.
- Risk factors for acute-phase stroke after LVAD remain understudied.
Purpose of the Study:
- To investigate the risk factors for symptomatic stroke in the acute phase (within 90 days) after LVAD implantation.
- To identify specific clinical and biochemical markers associated with acute stroke risk.
Main Methods:
- A retrospective analysis of 158 consecutive patients undergoing continuous-flow LVAD implantation.
- Patients were monitored for symptomatic stroke within 90 days post-implantation.
- Multivariate analysis was used to identify independent risk factors for acute stroke.
Main Results:
- Stroke occurred in 28 patients during the acute phase.
- Low cardiac output between 12-24 hours postoperatively was the sole independent risk factor for acute stroke (OR, 0.25; P=.024).
- Patients experiencing stroke had higher serum lactate dehydrogenase (LDH) levels postoperatively.
Conclusions:
- Perioperative low cardiac output and elevated LDH levels are associated with acute stroke after LVAD implantation.
- Maintaining adequate LVAD flow is crucial for preventing acute stroke.
- The findings suggest a potential link between pump performance, thrombosis, and stroke risk.
Objective:
Stroke is one of the major adverse events after left ventricular assist device implantation. Risk of stroke is the highest immediately after left ventricular assist device implantation and then increases again in chronic periods. There is no study that has analyzed risk factors for stroke in acute phase. We investigated the risk factors for stroke in the acute phase after left ventricular assist device implantation in the present study.
Methods:
Between October 2005 and December 2016, 158 consecutive patients (mean age, 43 ± 14 years; 34% were women) underwent continuous-flow left ventricular assist device (50 HeartMate II [Abbott Medical, Abbott Park, Ill], 38 DuraHeart [Terumo Heart, Ann Arbor, Mich], 33 Jarvik2000 [Jarvik Heart, New York, NY], 23 EVAHEART [Sun Medical, Moriyama City, Japan], 14 HeartWare [Framingham, Mass]) implantation in our institution. We analyzed the risk factors for a symptomatic stroke within 90 days after left ventricular assist device implantation.
Results:
Stroke occurred in 28 patients in the acute phase after left ventricular assist device implantation. Multivariate analysis revealed that low cardiac output (odds ratio, 0.25; 0.07-0.92; P = .024) during postoperative 12 to 24 hours was the only independent risk factor for stroke in the acute phase. Patients with stroke in the acute phase had higher serum lactate dehydrogenase levels at any point until postoperative 14 days. Patients with the HeartMate II device particularly showed a statistically significant negative relationship between cardiac output during postoperative 12 to 24 hours and serum lactate dehydrogenase levels at postoperative 14 days (r = -0.313, P = .03).
Conclusions:
Our study demonstrated that patients with perioperative lower cardiac output and higher lactate dehydrogenase level developed stroke in the acute phase after left ventricular assist device implantation. These results suggested that maintenance of sufficient left ventricular assist device flow is important in prevention of stroke, which may be related to subclinical pump thrombosis.
Related Concept Videos
Relative Risk
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Non-ohmic Devices
Consider a simple circuit consisting of a battery, a diode, and a resistor. A...
Mnemonic Devices
Acronyms
Acronyms are created by using the initial letters of a series of words to form a new word or phrase. This approach condenses complex information into a single, memorable entity. For example,...
Cardiac Output and Stroke Volume
In an average resting adult male, the typical cardiac...

